Form 4 for GEHC GE HealthCare
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-13 · accession 0001628280-24-023668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-15 | 2024-05-13+ | GEHC | Makela Jan | CEO, Imaging | M - OptEx | $71.84 | +87.2K | 71.7K | New | +$6.26M |
| DM | 2024-05-15 | 2024-05-13+ | GEHC | Makela Jan | CEO, Imaging | S - Sale+OE | $81.55 | -87.2K | 63.3K | -58% | -$7.11M |
| DM | 2024-05-15 | 2024-05-13+ | GEHC | Makela Jan | CEO, Imaging | M - OptEx | $0.00 | -87.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-05-13 | M | A | 20,227 | $63.51 | 83,575 | D | — | — | |
| 2 | Common | Common Stock, par value $0.01 per share | 2024-05-13 | S | D | 20,227 | $81.57 | 63,348 | D | — | — | (F1) The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). |
| 3 | Common | Common Stock, par value $0.01 per share | 2024-05-15 | S | D | 66,955 | $81.54 | 63,348 | D | — | — | (F2) The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). |
| 4 | Common | Common Stock, par value $0.01 per share | 2024-05-15 | M | A | 25,472 | $75.30 | 97,208 | D | — | — | |
| 5 | Common | Common Stock, par value $0.01 per share | 2024-05-15 | M | A | 33,095 | $76.37 | 130,303 | D | — | — | |
| 6 | Common | Common Stock, par value $0.01 per share | 2024-05-15 | M | A | 8,388 | $63.51 | 71,736 | D | — | — | |
| 7 | Derivative | Employee Stock Option (right to buy) | 2024-05-13 | M | D | 20,227 | $0.00 | 8,388 | D | $63.51 · — to 2030-03-02 | 20,227 Common Stock, par value $0.01 per share | (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2024-05-15 | M | D | 8,388 | $0.00 | 0 | D | $63.51 · — to 2030-03-02 | 8,388 Common Stock, par value $0.01 per share | (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2024-05-15 | M | D | 33,095 | $0.00 | 33,096 | D | $76.37 · — to 2031-07-01 | 33,095 Common Stock, par value $0.01 per share | (F5) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2024-05-15 | M | D | 25,472 | $0.00 | 0 | D | $75.30 · — to 2033-03-01 | 25,472 Common Stock, par value $0.01 per share | (F4) Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024. |